Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNEX CORPCGNX · Entity 3527 | Director · CEO & President | August 11, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNEX CORP
Report date August 11, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,884 |
Ending reported balance
After 2026-08-11 transaction · row 9
9 source rows · reconciled sequenceRow 1 · 2026-08-11 · Exercise / conversion · Acquired 1,600 · Balance 20,846 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 2 · 2026-08-11 · Sale · Disposed 1,600 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 3 · 2026-08-11 · Exercise / conversion · Acquired 4,000 · Balance 23,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 4 · 2026-08-11 · Sale · Disposed 4,000 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 5 · 2026-08-11 · Exercise / conversion · Acquired 4,000 · Balance 23,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 6 · 2026-08-11 · Sale · Disposed 4,000 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 7 · 2026-08-11 · Exercise / conversion · Acquired 7,000 · Balance 26,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 8 · 2026-08-11 · Sale · Disposed 7,000 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 9 · 2026-08-11 · Sale · Disposed 8,362 · Balance 10,884 F2: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.71 · Expires 2028-11-19 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-11 · Exercise / conversion · Disposed 4,000 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (November 19, 2018). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.84 · Expires 2028-10-31 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-08-11 · Exercise / conversion · Disposed 7,000 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4: The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.49 · Expires 2029-02-19 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-08-11 · Exercise / conversion · Disposed 4,000 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.44 · Expires 2028-02-20 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-08-11 · Exercise / conversion · Disposed 1,600 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.99 · Expires 2035-05-05 | Direct | 279,070 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 279,070 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.78 · Expires 2035-02-21 | Direct | 76,924 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 76,924 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.04 · Expires 2035-02-18 | Direct | 68,823 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 68,823 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.44 · Expires 2034-02-20 | Direct | 58,260 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 58,260 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.21 · Expires 2033-02-21 | Direct | 37,832 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 37,832 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.95 · Expires 2032-08-04 | Direct | 35,639 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 35,639 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.01 · Expires 2033-08-07 | Direct | 47,962 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 47,962 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.97 · Expires 2029-10-30 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 9,000 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.09 · Expires 2036-02-17 | Direct | 58,744 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 58,744 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.38 · Expires 2031-08-09 | Direct | 8,426 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 8,426 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-20 | Direct | 5,071 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · Balance 5,071 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-02-18 | Direct | 20,339 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · Balance 20,339 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-02-17 | Direct | 56,928 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · Balance 56,928 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F3: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (November 19, 2018).
F4: The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date.
F5: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2023 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 5,592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 14 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,592 Underlying: Common Stock · 5,592 shares Expires 2026-02-21 Read SEC document |
| February 21, 2023 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 37,832 | $0.00 Strike: $47.21 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 5 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,832 Underlying: Common Stock · 37,832 shares Expires 2033-02-21 Read SEC document |
| August 04, 2022 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 3,441 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 13 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,441 Underlying: Common Stock · 3,441 shares Expires 2025-08-04 Read SEC document |
| August 04, 2022 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 35,639 | $0.00 Strike: $47.95 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 6 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,639 Underlying: Common Stock · 35,639 shares Expires 2032-08-04 Read SEC document |
| February 22, 2022 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 1,552 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 12 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,552 Underlying: Common Stock · 1,552 shares Expires 2025-02-22 Read SEC document |
| August 09, 2021 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,426 | $0.00 Strike: $86.38 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 11 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,426 Underlying: Common Stock · 8,426 shares Expires 2031-08-09 Read SEC document |
| October 30, 2019 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $51.97 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 9 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-10-30 Read SEC document |
| February 19, 2019 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $51.49 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 8 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2029-02-19 Read SEC document |
| November 19, 2018 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $40.71 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 3 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2028-11-19 Read SEC document |
| October 31, 2018 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $42.84 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 4 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2028-10-31 Read SEC document |
| February 20, 2018 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,600 | $0.00 Strike: $56.44 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 10 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2028-02-20 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.